Why Your Doctor Put You on Antidepressants When You Needed Estrogen

By Dr. Shweta Patel, Board-Certified OB/GYN | Gaya Wellness

Published March 16, 2026 • 10-minute read

Let me tell you about the patient I see more than any other.

She's 43. Or 47. Or 51. She walks into my office — or logs onto our telehealth call — and the first thing she says is some version of: “I think I'm losing my mind.”

She can't sleep. She's anxious for no reason. She snaps at her kids and then cries about it. She can't find words in meetings. She has this low-grade dread that sits in her chest all day, and she can't explain why. Her doctor ran “normal labs” and told her she was fine. Then handed her a prescription for Lexapro.

That was six months ago. The Lexapro took the edge off — maybe. But something still isn't right. She doesn't feel like herself. And nobody has once asked about her hormones.

This is the most common story in perimenopause right now. And it is a clinical failure on a massive scale.

The Prescription That Misses the Point

Here's what happens in exam rooms across America every day: A woman in her late 30s, 40s, or early 50s presents with anxiety, mood swings, low mood, irritability, or panic attacks. Her physician pulls out a PHQ-9 depression screening questionnaire. She scores in the moderate range. She walks out with an SSRI prescription and a follow-up in six weeks.

Nobody asks about her cycle. Nobody asks about night sweats, hot flashes, brain fog, or changes in her period. Nobody orders estradiol, progesterone, or testosterone levels. Nobody considers that the anxiety devouring her life might be driven by the same endocrine shift that's disrupting her sleep, her cognition, and her ability to regulate her own emotions.

The data on this is staggering. Research published in The Pharmaceutical Journal found that approximately 40% of perimenopausal women report increased depressive symptoms during the transition — yet most clinicians fail to connect these symptoms to hormonal changes. A 2024 UCL study found that women are 40% more likely to develop depression during perimenopause than at other points in their lives. And yet, as the March 2026 Royal College of Psychiatrists position statement revealed, three in four women had no idea menopause could trigger a mental health condition at all.

If you don't know what's happening to you, you can't ask for the right help. And if your doctor doesn't know either — which, given that nearly half of UK medical schools don't include mandatory menopause education — you're going to get an antidepressant. Not because it's the right answer. Because it's the only answer they have.

The Data Your Doctor Hasn't Seen Yet

The Royal College of Psychiatrists' March 2026 position statement is the first time a major psychiatric body has formally addressed the intersection of menopause and mental health. And the findings are impossible to ignore.

The statement raised specific concerns that healthcare professionals are not routinely considering hormonal status when women in their late 30s through early 50s present with psychiatric symptoms. It called for menopause to be part of standard mental health assessments. It recommended better training for clinicians and greater integration between mental health services and menopause care.

But the data goes even further. A 2026 clinical study published by Liverpool John Moores University and Newson Health found that roughly 1 in 6 women experience suicidal thoughts during perimenopause and menopause that are not being identified or treated effectively. Let that number settle. One in six. These are women whose hormonal symptoms are so severe that they're experiencing suicidal ideation — and the system is missing it.

Then there's the brain data. A February 2026 study from the University of Cambridge, published in Psychological Medicine, found that menopause is associated with reduced grey matter volume in brain regions tied to memory and emotional regulation. Women who had gone through menopause were more likely to seek help for anxiety and depression, scored higher on depression questionnaires, and were more likely to be prescribed antidepressants.

The picture is clear: menopause physically changes the brain. It rewires mood regulation. It disrupts the very neurotransmitter systems that antidepressants target. And yet, the standard of care in most medical offices is to treat the symptom with an SSRI and never investigate the cause.

Why Antidepressants Alone Don't Fix a Hormonal Problem

Let me be clear about something: I am not anti-antidepressant. SSRIs and SNRIs save lives. They are critical tools for clinical depression and anxiety disorders. Some women in perimenopause genuinely need them — and some need them alongside hormone replacement therapy.

But prescribing an antidepressant without first evaluating hormonal status is like prescribing a painkiller for a broken bone without setting the fracture. You might feel 20% better. But the underlying problem is still there, getting worse.

Here's the endocrinology your doctor probably never explained:

• Estrogen directly regulates serotonin. It affects serotonin receptor density, serotonin synthesis, and serotonin transport in the brain. When estrogen drops during perimenopause, your brain's entire serotonin system destabilizes. An SSRI tries to keep more serotonin in the synapse — but if the system producing and regulating serotonin is compromised, you're fighting upstream.
• Progesterone drives GABA activity. Progesterone metabolizes into allopregnanolone, which acts on GABA receptors — your brain's primary calming mechanism. When progesterone declines, GABA activity falls. The result is anxiety, insomnia, and a nervous system stuck in overdrive. No SSRI targets this pathway.
• Testosterone supports dopamine. Testosterone regulates dopamine release — the neurotransmitter responsible for motivation, pleasure, and focus. When testosterone declines, women lose drive, lose interest in things they used to enjoy, and feel a flatness that looks exactly like depression. Antidepressants don't restore dopamine regulation.
• Cortisol dysregulation compounds everything. Hormonal instability during perimenopause often disrupts the HPA axis, leading to cortisol patterns that amplify anxiety, disrupt sleep, and impair cognitive function. This creates a vicious cycle that antidepressants cannot break.

UK menopause guidelines are explicit: antidepressants should not be used as first-line treatment for the low mood associated with perimenopause and menopause. The hormonal evaluation should come first. And yet, in most primary care settings, it doesn't.

The Estrogen Shortage That's Making Everything Worse

As if the misdiagnosis problem wasn't bad enough, there's now a supply crisis making it harder for women who do get the right diagnosis to access treatment.

As of March 2026, estradiol transdermal patches — the most commonly prescribed form of menopausal hormone therapy — are in shortage across the United States. NPR, CNN, and AARP have all reported on women bouncing between pharmacies, switching brands month to month, and going weeks without their medication while symptoms roar back.

The shortage has multiple drivers. The FDA removed the black box warning on hormone therapy products in November 2025 — a long-overdue correction based on decades of updated evidence showing that the original 2002 Women's Health Initiative findings were misapplied to younger women. Demand surged. But manufacturing capacity didn't keep up. Major producers including Amneal and Sandoz have confirmed supply constraints.

For women managing hormonal symptoms including mood disruption, this shortage is not an inconvenience. It's a medical emergency. Going without estrogen abruptly can trigger a return of every symptom — the anxiety, the insomnia, the mood crashes. And for women who fought to get the right diagnosis in the first place, it's a cruel irony: they finally have the prescription, and now the pharmacy can't fill it.

This is where having a physician who understands the full landscape of hormonal delivery matters. Patches are not the only option. Estradiol gels, sprays, and compounded bioidentical formulations remain available through specialized practices. At Gaya Wellness, we prescribe compounded bioidentical hormones through FDA-regulated 503B pharmacies — which means our patients are not subject to the same retail supply chain disruptions. Access to care should not depend on which pharmacy has stock this week.

What a Complete Perimenopause Mental Health Assessment Actually Looks Like

If you're a woman between 35 and 55 presenting with new or worsening anxiety, depression, irritability, or cognitive symptoms, here is the minimum standard of care you deserve — and it is dramatically different from what most women receive:

Step 1: A real hormonal panel — not “normal labs.”
Estradiol. Progesterone. Total and free testosterone. DHEA-S. Full thyroid panel (TSH, free T3, free T4, thyroid antibodies). Fasting insulin. Cortisol. Vitamin D. A complete metabolic panel. This is a 50+ biomarker workup. It takes 15 minutes to order and changes everything.

Step 2: A conversation with someone who understands both hormones and mental health.
Not a chatbot. Not a 90-second telehealth screening. A board-certified physician who can look at your symptoms, your labs, your history, and your cycle together — and determine whether your anxiety is primarily hormonal, primarily psychiatric, or (as is often the case) both.

Step 3: Hormonal optimization if indicated.
If your labs confirm what your symptoms are screaming — that estrogen, progesterone, or testosterone are depleted or unstable — HRT becomes the foundation. Estrogen restores serotonin function. Progesterone restores GABA-mediated calm. Testosterone restores dopamine-driven motivation. For many women, this alone resolves the mood symptoms that antidepressants couldn't touch.

Step 4: Layer additional support as needed.
Some women need both HRT and an antidepressant — and there's evidence that estrogen can actually enhance SSRI efficacy. Some need targeted peptide therapy for sleep or cognitive function. Some need nutritional optimization and cortisol management. The point is: it's a customized plan, not a generic prescription.

This is what we built the Hormonal Agency™ program at Gaya Wellness to deliver. A physician-led, evidence-based approach to hormonal health that starts with your biology — not a prescription pad.

The System That Keeps Failing Women Over 40

Let me name the problem plainly.

The average primary care visit is 18 minutes. In that window, a physician is expected to assess, diagnose, and treat whatever you walked in with. If you're a 46-year-old woman presenting with anxiety — and your doctor has no menopause training, no time to order a hormonal panel, and a prescription pad that offers a fast solution — you're going to get an SSRI. It's not malice. It's a system designed for speed, not accuracy.

Telehealth platforms have made this worse, not better. The same companies that will ship you a semaglutide pen in 72 hours will prescribe an antidepressant after a five-minute video call. No labs. No hormonal assessment. No follow-up conversation about whether the medication is actually working or whether the underlying cause has been addressed.

And here's the piece that makes me angriest: the women who are most affected are the women who trust the system the most. They go to their doctor. They answer the questionnaire honestly. They take the medication they're prescribed. They do everything right. And they still feel wrong — because nobody investigated why.

At Gaya Wellness, I built our programs specifically for this gap. The Hormonal Agency™ program gives women what the system won't: a comprehensive hormonal evaluation, a board-certified OB/GYN who understands the endocrine system, and a treatment plan that addresses root causes — not just symptoms.

And for women who are also struggling with the weight changes that accompany perimenopause, our Weight Loss Concierge program integrates hormonal optimization with medical weight loss — because mood and metabolism are two sides of the same hormonal coin:

• Foundation (GLP-1 Access) — $149/mo: Physician-led coaching with 50+ biomarker panel and prior authorization support for insurance-covered GLP-1 medications.
• Premium (GLP-1 Included) — $349/mo: Everything in Foundation plus compounded semaglutide or tirzepatide shipped to your door with physician-managed dosing.
• Concierge (GLP-1 + HRT) — $549/mo: The complete protocol. GLP-1 medication combined with bioidentical hormone replacement therapy — the approach the research says produces the best outcomes.

You're Not Losing Your Mind. You're Losing Estrogen.

If you're reading this and feeling a wave of recognition — the anxiety that came from nowhere, the antidepressant that only half-works, the creeping fear that something is fundamentally wrong with you — I need you to hear this:

You are not broken. You are not crazy. Your brain is responding to a hormonal shift that nobody explained to you.

Perimenopause is not a character flaw. It's an endocrine event. And it requires an endocrine evaluation — not just a psychiatric one.

You deserve a physician who will order the right labs, interpret them in context, and build a treatment plan around your biology. Not a 5-minute screening that ends with a prescription you didn't need.

The Hormonal Agency™ program at Gaya Wellness was built for exactly this. Board-certified OB/GYN from day one. 50+ biomarker panel before any prescription. A medical relationship — not a transaction. And a physician who will never dismiss what you're feeling.

Your body changed. Now your care needs to change with it.